PRODUCTS Data Products Overview RWD360™ Patient360 Genome360 Custom Data INDEPENDENT, SCALABLE AND SPECIALIZED Real-World Data for Precision Evidence ConcertAI’s rich suite of independent real-world data products are fit-for-purpose to meet a variety of research and real-world evidence uses cases across the enterprise. Post-Approval Clinical Development Comparative effectiveness in real-world populations compared to clinical trials Study feasibility analyses Patient population comparisons and analytics Characteristics of patient journey and treatment sequencing over time Adverse event detection and evaluation Treatment patterns and analysis Biomarker data impact on treatment selection and outcomes RWD360 is a vast repository of pan tumor clinical data for broad analyses with the highest epidemiological relevance. Validated AI models enrich data for scale; claims linkage provides more complete insights into patient journeys. Request a Demo All Tumors High Coverage AI-Enriched Reasons for RWD360 Request Information COMPARE CHARACTERISTICS SEE TREATMENT SEQUENCING COMBINE CLINICAL CRITERIA Customer Value for RWD360 CLINICAL DEVELOPMENT LEADERS DATA SCIENTIST & TRIAL ANALYTICS EXPERTS CHIEF DEVELOPMENT OFFICERS Patient360 is an off-the-shelf, deeply abstracted data product that removes the need for bespoke curation and allows direct insights into current standard of care on emerging disease and treatment dynamics. Request a Demo Deepest Industry Abstraction On-Demand Datasets Reasons for Patient360 Request Information IDENTIFY STUDY FEASIBILITY POST-APPROVAL RWE TRACK SAFETY COST-OF-CARE ANALYSES Customer Value for Patient360 CLINICAL DEVELOPMENT LEADERS POST-APPROVAL/EPI-SAFETY EXECUTIVES BRAND MANAGERS AML Bladder Breast Gastric-Esophageal Liver Lung Melanoma Pancreatic Prostate Renal All Other Cancers RESEARCH STUDY Performance of Proxy Measures Compared with Direct Observation of Progression-Free Survival See results from findings presented at ISPOR 2020 and ASCO 2020 on the performance of proxy measures against directly-observed measures of PFS by using structured and unstructured information from ConcertAI’s Oncology Real-World Database. See Research Study Genome360 provides in-depth understanding of treatment profiles with data from NGS panels and structured and unstructured fields. Request a Demo Full NGS Panel Linked Genomic-Clinical Deepest Industry Abstraction Reasons for Genome360 Request Information BIOMARKER TESTING RESULTS IDENTIFY PATIENTS BY GENE VARIANTS ASSESS TREATMENTS AND OUTCOMES Customer Value for Genome360 CLINICAL DEVELOPMENT LEADERS POST-APPROVAL/EPI-SAFETY EXECUTIVES BRAND MANAGERS Our team of HEOR and clinical oncology experts build unique data assets to support research questions that demand deeper insights. Request a Demo Oncology and HEOR Expertise Extensive Knowledge of RWD Biostatistical Design and Execution Regulatory Support and Publications Reasons for ConcertAI Custom Data Request Information PRECISE PATIENT JOURNEYS DEPTH OF INFORMATION LONGITUDINAL DATASETS Use Cases Commercial Solutions Study Design Regulatory Use External Control Arms AML Bladder Breast Gastric-Esophageal Lung Liver Melanoma Pancreatic Prostate Renal All Other Cancers Products & Services Data Products Predictive Patient STAR SPRINT Services Research Publications ERACE Resources Content Webinars and Events News Blog About Us Our Team Careers Investors Contact Us Request a Demo © 2017-2021 ConcertAI. All Rights Reserved. ConcertAI is a SymphonyAI company. Privacy Policy Terms of Use Privacy Policy Accept